Witjes JA - Search Results

1

Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA.

Daneshmand S, Schuckman AK, Bochner BH, Cookson MS, Downs TM, Gomella LG, Grossman HB, Kamat AM, Konety BR, Lee CT, Pohar KS, Pruthi RS, Resnick MJ, Smith ND, Witjes JA, Schoenberg MP, Steinberg GD. Daneshmand S, et al. Among authors: witjes ja. Nat Rev Urol. 2014 Oct;11(10):589-96. doi: 10.1038/nrurol.2014.245. Epub 2014 Sep 23. Nat Rev Urol. 2014. PMID: 25245244 Review.

2

Expression of markers for transitional cell carcinoma in normal bladder mucosa of patients with bladder cancer.

Witjes JA, Umbas R, Debruyne FM, Schalken JA. Witjes JA, et al. J Urol. 1995 Dec;154(6):2185-9. J Urol. 1995. PMID: 7500486

3

Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer.

Kiemeney LA, Witjes JA, Heijbroek RP, Verbeek AL, Debruyne FM. Kiemeney LA, et al. Among authors: witjes ja. J Urol. 1993 Jul;150(1):60-4. doi: 10.1016/s0022-5347(17)35397-1. J Urol. 1993. PMID: 8510276

4

Quanticyt: karyometric analysis of bladder washing for patients with superficial bladder cancer.

van der Poel HG, Witjes JA, van Stratum P, Boon ME, Debruyne FM, Schalken JA. van der Poel HG, et al. Among authors: witjes ja. Urology. 1996 Sep;48(3):357-64. doi: 10.1016/S0090-4295(96)00210-5. Urology. 1996. PMID: 8804485 Free article. Clinical Trial.

5

Familial transitional cell carcinoma among the population of Iceland.

Kiemeney LA, Moret NC, Witjes JA, Schoenberg MP, Tulinius H. Kiemeney LA, et al. Among authors: witjes ja. J Urol. 1997 May;157(5):1649-51. J Urol. 1997. PMID: 9112497

6

Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer.

Van der Poel HG, Van Balken MR, Schamhart DH, Peelen P, de Reijke T, Debruyne FM, Schalken JA, Witjes JA. Van der Poel HG, et al. Among authors: witjes ja. Urology. 1998 Jan;51(1):44-50. doi: 10.1016/s0090-4295(97)00496-2. Urology. 1998. PMID: 9457287

7

Presence of carcinoma in situ and high 2C-deviation index are the best predictors of invasive transitional cell carcinoma of the bladder in patients with high-risk Quanticyt.

van Rhijn BW, van der Poel HG, Boon ME, Debruyne FM, Schalken JA, Witjes JA. van Rhijn BW, et al. Among authors: witjes ja. Urology. 2000 Mar;55(3):363-7. doi: 10.1016/s0090-4295(99)00460-4. Urology. 2000. PMID: 10699611

8

Gender differences in stage distribution of bladder cancer.

Mungan NA, Kiemeney LA, van Dijck JA, van der Poel HG, Witjes JA. Mungan NA, et al. Among authors: witjes ja. Urology. 2000 Mar;55(3):368-71. doi: 10.1016/s0090-4295(99)00481-1. Urology. 2000. PMID: 10699612

9

Gender differences in stage-adjusted bladder cancer survival.

Mungan NA, Aben KK, Schoenberg MP, Visser O, Coebergh JW, Witjes JA, Kiemeney LA. Mungan NA, et al. Among authors: witjes ja. Urology. 2000 Jun;55(6):876-80. doi: 10.1016/s0090-4295(00)00523-9. Urology. 2000. PMID: 10840099

10

Management of superficial bladder cancer with intravesical chemotherapy: an update.

Witjes JA, Mungan NA, Debruyne FM. Witjes JA, et al. Urology. 2000 Jul;56(1):19-21. doi: 10.1016/s0090-4295(00)00572-0. Urology. 2000. PMID: 10869610 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

518 results

Search Page

Filters